vs
Prenetics Global Ltd(PRE)与Resolute Holdings Management, Inc.(RHLD)财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是Prenetics Global Ltd的1.3倍($117.7M vs $92.0M)
Prenetics是一家总部位于中国香港的健康科学企业,业务辐射美国地区,专注于癌症等疾病的早期筛查、预防与干预诊疗,致力于帮助人们更早发现健康风险,助力提升相关疾病的治疗效果,推动肿瘤等重疾的早防早治,守护公众健康。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业,核心业务布局于非洲地区,目前运营两座金矿,分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿,专注于黄金资源的勘探、开采及相关运营管理工作。
PRE vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.3倍
$92.0M
损益表 — Q1 FY2023 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $92.0M | $117.7M |
| 净利润 | — | $-1.7M |
| 毛利率 | 39.2% | 55.7% |
| 营业利润率 | — | 30.2% |
| 净利率 | — | -1.5% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益(稀释后) | — | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PRE
RHLD
| Q4 25 | — | $117.7M | ||
| Q3 25 | — | $120.9M | ||
| Q2 25 | — | $119.6M | ||
| Q1 25 | — | $103.9M | ||
| Q1 23 | $92.0M | — | ||
| Q3 22 | $74.7M | — | ||
| Q1 22 | $57.5M | — |
净利润
PRE
RHLD
| Q4 25 | — | $-1.7M | ||
| Q3 25 | — | $-231.0K | ||
| Q2 25 | — | $-611.0K | ||
| Q1 25 | — | $-3.4M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
毛利率
PRE
RHLD
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | — | 52.5% | ||
| Q1 23 | 39.2% | — | ||
| Q3 22 | 34.5% | — | ||
| Q1 22 | 38.2% | — |
营业利润率
PRE
RHLD
| Q4 25 | — | 30.2% | ||
| Q3 25 | — | 34.3% | ||
| Q2 25 | — | 34.0% | ||
| Q1 25 | — | 24.7% | ||
| Q1 23 | — | — | ||
| Q3 22 | -7.2% | — | ||
| Q1 22 | — | — |
净利率
PRE
RHLD
| Q4 25 | — | -1.5% | ||
| Q3 25 | — | -0.2% | ||
| Q2 25 | — | -0.5% | ||
| Q1 25 | — | -3.2% | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
每股收益(稀释后)
PRE
RHLD
| Q4 25 | — | $-0.20 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.39 | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | — | $6.5M |
| 总资产 | — | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势,按日历期对齐
现金及短期投资
PRE
RHLD
| Q4 25 | — | $205.5M | ||
| Q3 25 | — | $148.0M | ||
| Q2 25 | — | $99.9M | ||
| Q1 25 | — | $71.0M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
总债务
PRE
RHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
股东权益
PRE
RHLD
| Q4 25 | — | $6.5M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | — | $8.9M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
总资产
PRE
RHLD
| Q4 25 | — | $333.4M | ||
| Q3 25 | — | $293.2M | ||
| Q2 25 | — | $253.3M | ||
| Q1 25 | — | $214.3M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
负债/权益比
PRE
RHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $196.1M |
| 自由现金流经营现金流 - 资本支出 | — | $189.2M |
| 自由现金流率自由现金流/营收 | — | 160.8% |
| 资本支出强度资本支出/营收 | — | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $313.2M |
8季度趋势,按日历期对齐
经营现金流
PRE
RHLD
| Q4 25 | — | $196.1M | ||
| Q3 25 | — | $59.6M | ||
| Q2 25 | — | $48.9M | ||
| Q1 25 | — | $18.4M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
自由现金流
PRE
RHLD
| Q4 25 | — | $189.2M | ||
| Q3 25 | — | $58.6M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | — | $17.8M | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
自由现金流率
PRE
RHLD
| Q4 25 | — | 160.8% | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 17.1% | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
资本支出强度
PRE
RHLD
| Q4 25 | — | 5.8% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.6% | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q1 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图